Get the Stockscreener App
3.01
6.36%
0.18
After Hours:
3.01
Whitehawk Therapeutics Inc stock is traded at $3.01, with a volume of 377.90K.
It is up +6.36% in the last 24 hours and up +17.12% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$2.83
Open:
$2.85
24h Volume:
377.90K
Relative Volume:
2.50
Market Cap:
$141.86M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+11.07%
1M Performance:
+17.12%
6M Performance:
+76.02%
1Y Performance:
+0.00%
1-Day Range:
$2.8301
$3.03
1-Week Range:
$2.63
$3.03
52-Week Range:
$1.39
$3.7699
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
3.01 | 133.37M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-26 | Initiated | Oppenheimer | Outperform |
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
Oppenheimer Begins Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - Defense World
Oppenheimer initiates Whitehawk Therapeutics (WHWK) with Outperform Feb 2026 - Meyka
Oppenheimer Initiates Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Trading 0.7% HigherStill a Buy? - MarketBeat
Retail Trends: Can FreightCar America Inc be recession proofJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Investment Recap: Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Whitehawk Therapeutics (WHWK) price target increased by 125.00% to 4.59 - MSN
Support Test: Should I set a stop loss on Onfolio Holdings IncTake Profit & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Whitehawk Therapeutics Inc sustain its profitability2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth - simplywall.st
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7%Here's What Happened - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7% – Here’s What Happened - Defense World
Published on: 2026-01-10 19:11:09 - ulpravda.ru
Why Whitehawk Therapeutics Inc. stock is favored by top institutionsJuly 2025 Technicals & Reliable Trade Execution Plans - Улправда
Following a 26% decline over last year, recent gains may please Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) hedge funds owners - Sahm
Will Whitehawk Therapeutics Inc. stock continue upward momentumJuly 2025 Chart Watch & Verified Stock Trade Ideas - ulpravda.ru
Why Whitehawk Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Summary & Free Expert Approved Momentum Trade Ideas - Улправда
How Whitehawk Therapeutics Inc. stock performs in rate cut cyclesPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru
Will Whitehawk Therapeutics Inc. stock pay special dividendsEarnings Growth Summary & Weekly High Return Stock Opportunities - ulpravda.ru
Why institutional investors increase stakes in Whitehawk Therapeutics Inc. (3350) stockJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Whitehawk receives FDA clearance for PTK7-targeted cancer drug - Investing.com
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - The AI Journal
Published on: 2026-01-07 23:20:08 - Улправда
Can Whitehawk Therapeutics Inc. stock weather global recessionCandlestick Trading Patterns & Access Powerful Market Insights - Улправда
Free cash flow per share of Whitehawk Therapeutics, Inc. – DUS:3350 - TradingView — Track All Markets
Whitehawk Therapeutics, Inc.Common Stock (Nasdaq:WHWK) Stock Quote - FinancialContent
Whitehawk Therapeutics (NASDAQ:WHWK) Now Covered by Jones Trading - MarketBeat
Whitehawk Therapeutics (WHWK) Receives Buy Rating from Jones Tra - GuruFocus
Jones Trading initiates coverage on Whitehawk Therapeutics stock with Buy rating - Investing.com Canada
Published on: 2025-12-21 14:50:11 - Улправда
Analyzing Whitehawk Therapeutics (NASDAQ:WHWK) & Vaccinex (NASDAQ:VCNX) - Defense World
Will Whitehawk Therapeutics Inc. stock recover faster than market2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда
Will Whitehawk Therapeutics Inc. (3350) stock test record highs in 2025July 2025 Setups & Smart Investment Allocation Tips - Улправда
Will Whitehawk Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Weekly Breakout Stock Alerts - ulpravda.ru
What risks investors should watch in Whitehawk Therapeutics Inc. stockJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - Улправда
Published on: 2025-12-19 20:40:41 - Улправда
Investment Recap: Will Whitehawk Therapeutics Inc. stock maintain momentum in 20252025 Short Interest & Weekly Breakout Watchlists - Улправда
Is Whitehawk Therapeutics Inc. stock a buy for dividend growthJuly 2025 EndofMonth & Long-Term Safe Return Strategies - DonanımHaber
Can Whitehawk Therapeutics Inc. (3350) stock double in coming yearsMarket Risk Analysis & Weekly High Conviction Ideas - DonanımHaber
Why Whitehawk Therapeutics Inc. stock remains resilientQuarterly Trade Review & Breakout Confirmation Alerts - Улправда
How interest rate cuts could boost Whitehawk Therapeutics Inc. stockOil Prices & Weekly Setup with ROI Potential - ulpravda.ru
What macro factors could drive Whitehawk Therapeutics Inc. (3350) stock higher2025 Sector Review & Stepwise Swing Trade Plans - Улправда
Is Whitehawk Therapeutics Inc. stock a dividend growth opportunityPortfolio Return Summary & Real-Time Market Sentiment Reports - Улправда
Whitehawk Therapeutics Earnings Notes - Trefis
Bond Watch: Is Whitehawk Therapeutics Inc stock a top pick in earnings seasonMarket Sentiment Review & Entry Point Strategy Guides - moha.gov.vn
Financial Comparison: Whitehawk Therapeutics (NASDAQ:WHWK) vs. BetterLife Pharma (OTCMKTS:PVOTF) - Defense World
Shorts Report: What risks investors should watch in Whitehawk Therapeutics Inc stockExit Point & Smart Investment Allocation Tips - moha.gov.vn
Will Whitehawk Therapeutics Inc. (3350) stock profit from automation waveStop Loss & Daily Stock Trend Reports - Newser
What makes Whitehawk Therapeutics Inc. stock attractive to growth fundsJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):